Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Researchers present new NR1I2 agonists

Aug. 9, 2018

Bayer patents MKNK1 inhibitors

Aug. 9, 2018

Sichuan Kelun-Biotech Biopharmaceutical patents FXR agonists

Aug. 8, 2018

NHRI synthesizes new CXCR4 ligands

Aug. 8, 2018

U.S. researchers identify ITGA5 antagonists

Aug. 8, 2018

Korean researchers divulge new antiviral compounds

Aug. 8, 2018

Salvensis patents compounds for schistosomiasis

Aug. 8, 2018

Japanese researchers synthesize new analgesic drugs

Aug. 7, 2018

Mebias Discovery patents new compounds for pain

Aug. 7, 2018

XinXiang Medical University divulges ANO5-targeting siRNAs

Aug. 6, 2018

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...